期刊文献+

姜黄素衍生物C15对白血病K562/A02细胞多药耐药的逆转作用 被引量:3

Reversal effects of curcumin derivative C15 on multidrug resistance of leukemia K562/A02 cells
原文传递
导出
摘要 目的:探讨姜黄素衍生物C15对人白血病K562/A02细胞多药耐药(multidrug resistance,MOR)的逆转作用及其作用机制。方法:四甲基偶氮唑蓝(MTT)法检测细胞增殖;流式细胞术检测P-糖蛋白(P-gp)外排泵功能和细胞周期;免疫印迹法检测蛋白表达;P-gp-GloTM Assay System试剂盒检测P-gp ATP水解酶(ATPase)活性。结果:C15对K562/A02细胞半数抑制浓度(IC50)大于50μmol·L-1。对K562/A02细胞无明显细胞毒的浓度为2.5,5.0,10.0μmol·L-1的C15逆转对K562/A02细胞对阿霉素(ADR)耐药的倍数分别为2.60,5.39,11.39,对长春新碱(vincristine,VCR)耐药的倍数分别为4.50,18.07,124.35,但是对非P-gp底物的化疗药物顺铂(cisplatin,CIS)和敏感细胞K562基本无逆转效果。2.5,5.0,10.0μmol·L-1 C15可以增加耐药细胞K562/A02胞内罗丹明123(Rh-123)的蓄积量分别为1.93,2.30,2.47倍。C15增加阿霉素(adriamycin,ADR)在K562/A02细胞中的蓄积水平,降低P-gp介导的Rh-123外排速率。2.5,10.0μmol·L-1 C15与300 nmol·L-1 VCR联合作用后,可使K562/A02细胞的G2/M期比例从9.36%增加到67.57%和69.38%。C15对P-gp蛋白和ATPase的活性没有抑制作用。结论:C15可能是P-gp的非衣物型抑制剂,且具有逆转K562/A02细胞MDR的作用,该作用与其抑制细胞P-gp的外排泵功能有关。 OBJECTIVE To investigate reversal effects of curcumin derivative C15 on multidrug resistance(MDR)in K562/A02 cells,and explore underlying mechanisms.METHODS Cell proliferation was detected by MTT method.P-gp function and cell cycle were measured by flow cytometry.Expression of proteins was detected by Western blot.Activity of P-gp ATPase was measured by P-gp-GloTM Assay System kit.RESULTS IC50 values of C15 on K562/A02 cells were greater than 50mol·L^-1.Compared with control,reversal fold of multidrug resistance to ADR or VCR were 2.60,5.39 and 11.39 folds or4.50,18.07 and 124.35 folds by 2.5,5.0and 10.0mol·L^-1 C15 in K562/A02 cells,respectively.However,it almost had no effect on non-P-gp substrate cisplatin(CIS)or its sensitive K562 cells.The accumulation of Rh-123 by 2.5,5.0and 10.0mol·L^-1 C15 were 1.93,2.30 and 2.47 folds when compared with control.In addition,C15 could increase accumulation of ADR and decreased P-gp-mediated efflux rate of Rh-123.2.5 and 10 mol·L^-1 C15 arrested G2/M phase of K562/A02 from9.36%to 67.57% and 69.38% when jointly treated with 300 nmol·L^-1 VCR.C15 had no inhibitive effects on expression of P-gp at protein level and on hydrolysis activity of ATPase of P-gp.CONCLUSION C15 may be a run-substrate inhibitor of P-gp,and hare the reversal effect on MDR can reverse multidrug resistance in K562/A02 cells,which is related with inhibition of efflux function of P-gp.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2015年第18期1637-1642,共6页 Chinese Journal of Hospital Pharmacy
基金 福建省中青年教师教育科研基金资助项目(编号:JA13151)
关键词 姜黄素衍生物C15 K562/A02细胞 多药耐药 逆转 curcumin derivative C15 K562/A02 cells multidrug resistance reverse
  • 相关文献

参考文献16

  • 1Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters [J]. Nat Rev Cancer, 2002, 2(1)..48-58.
  • 2Thomas H, Coley HM. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glyco protein [J]. Cancer Control, 2003, 10(2) : 159-165.
  • 3Tan B, Piwnica Worms D, Ratner L. Multidrug resistance transporters and modulation [J]. Curr Opin Oncol, 2000, 12 (5) :450-458.
  • 4Palmeira A, Sousa E, Vasconcelos MH, et al. Three decades of P-gp inhibitors:skimming through several generations and scaffolds [J]. Curr Med Chem, 2012, 19(13) : 1946-2025.
  • 5Coley HM. Overcoming multidrug resistance in cancer: clinical studies of l>glycoprotein inhibitors [J]. Methods Mol Biol. , 2010, 596:341-358.
  • 6Kant V, Gopal A, Pathak NN, etal. Antioxidant and anti-in- flammatory potential of curcumin accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats [J]. Int Immunopharmacol, 2014 , 20(2):322-330.
  • 7Reddy CA, Somepalli V, Golakoti T, et al. Mitoehondrial targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin [J]. PLoS One, 2014, 9 (3) : e89351.
  • 8Chearwae W, Anuchapreeda S, Nandigama K, et al. Bio- chemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder [J]. Biochem Pharmacol, 2004, 68(10):2043-2052.
  • 9Limtrakul P, Chearwae W, Shukla S, et al. Modulation of function of three ABC drug transporters, P-glycoprotein (AB- CB1), mitoxantrone resistance protein (ABCG2) and multi- drug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin [J]. Mol Cell Biochem, 2007, 296(1-2) :85-95.
  • 10Chearwae W, Wu CP, Chu HY, etal. Curcuminoids purified from turmeric powder modulate the function of human multi drug resistance protein 1 (ABCC1) [J]. Cancer Chemother Pharmacol, 2006, 57(3) :376-388.

同被引文献70

引证文献3

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部